Shanghai Allist Pharmaceuticals Co., Ltd.
688578.SSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
498
Cost of Revenue
24
Gross Profit
474
Gross Margin
95.3%
Operating Income
229
Operating Margin
45.9%
Net Income
200
Net Margin
40.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
212
EBITDA Margin
42.5%
2023
12/31/2023
Revenue
283
Cost of Revenue
15
Gross Profit
267
Gross Margin
94.5%
Operating Income
92
Operating Margin
32.6%
Net Income
90
Net Margin
31.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
82
EBITDA Margin
29.1%
2022
12/31/2022
Revenue
111
Cost of Revenue
7
Gross Profit
104
Gross Margin
94.0%
Operating Income
18
Operating Margin
16.2%
Net Income
18
Net Margin
16.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
8
EBITDA Margin
7.4%
2021
12/31/2021
Revenue
74
Cost of Revenue
4
Gross Profit
70
Gross Margin
94.3%
Operating Income
3
Operating Margin
4.1%
Net Income
3
Net Margin
3.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-8
EBITDA Margin
-10.6%
2020
12/31/2020
Revenue
0
Cost of Revenue
0
Gross Profit
0
Gross Margin
71.2%
Operating Income
-43
Operating Margin
-55350.3%
Net Income
-43
Net Margin
-55361.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-49
EBITDA Margin
-62383.2%